During the past decade, Onkopraxis Probstheida conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkopraxis Probstheida" #1 collaborator was "Cancer Trials Ireland" with 1 trials as a collaborator, "Crolll Gmbh" with 1 trials as a collaborator, "Grupo Español de Leucemia Linfocítica Crónica (GELLC)" with 1 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA)" with 1 trials as a collaborator and "Nordic CLL Study Group (NCLLSG)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Onkopraxis Probstheida" are "Chronic Lymphoid Leukemia" (1 trials), "Locally Advanced Pancreatic Cancer" (1 trials) and "Metastatic Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Onkopraxis Probstheida" in a lesser frequency.

Most popular intervention types in "Onkopraxis Probstheida" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (1 trials), "Irinotecan Liposomal Injection [Onivyde]" (1 trials), "Obinutuzumab" (1 trials) and "Venetoclax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkopraxis Probstheida" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Onkopraxis Probstheida". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Onkopraxis Probstheida, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkopraxis Probstheida, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".